Jul. 22 at 1:36 PM
$ARE just inked its biggest life science expansion lease ever — what’s the impact on the stock? 🧬
Despite beating Q2 estimates with AFFO per share of
$2.33, ARE faces headwinds with lower occupancy and a jump in interest expenses 📉. The stock carries a Zacks Rank #5 (Strong Sell), urging caution.
Find out what this means for investors 👉 https://www.zacks.com/stock/news/2602858/alexandrias-q2-affo-beats-estimates-occupancy-declines?cid=sm-stocktwits-2-2602858-body-2965&ADID=SYND_STOCKTWITS_TWEET_2_2602858_BODY_2965